Moderate

Oropharyngeal & oesophageal candidiasis (oral thrush; Candida oesophagitis)

White plaques / odynophagia; topical for oral, systemic fluconazole for oesophageal; seek underlying immunosuppression · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Mucosal Candida (usually C. albicans) infection. Oropharyngeal (thrush): removable white plaques, soreness, altered taste. Oesophageal: odynophagia/dysphagia/retrosternal pain - an AIDS-defining illness and marker of immunosuppression. Look for predisposing factors: HIV, steroids (incl. inhaled), antibiotics, diabetes, dentures, chemotherapy, xerostomia. Oesophageal disease needs systemic azole.

Red flags

  • Odynophagia/dysphagia - oesophageal disease; consider AIDS-defining, test HIV
  • Failure to respond to azole - resistant/non-albicans Candida or alternative pathogen (CMV/HSV)
  • Extensive disease in a young previously well adult - undiagnosed immunosuppression
  • Unable to swallow / dehydration
  • Risk of dissemination in profoundly neutropenic patients

Assessment

Differential diagnosis

  • Oral leukoplakia, lichen planus, oral hairy leukoplakia (EBV)
  • Herpetic / aphthous / CMV oesophagitis/ulcers
  • Pill or reflux oesophagitis
  • Oral SCC
  • Angular cheilitis

Investigations

  • Clinical diagnosis for oral thrush (scrapeable plaques leaving erythematous base)
  • Empirical treatment-trial for oesophageal candidiasis in at-risk host; endoscopy + biopsy/brushings if no response or diagnostic doubt (exclude CMV/HSV)
  • Identify underlying cause: HIV test (especially oesophageal/recurrent), capillary glucose/HbA1c, review inhaled/systemic steroids, recent antibiotics, immunosuppression
  • Consider C. glabrata/krusei (azole resistance) if refractory

Management

  • Treat oral thrush topically first-line; systemic azole if extensive, refractory or immunocompromised
  • Treat oesophageal candidiasis with systemic fluconazole (topical inadequate)
  • Address predisposing factors: rinse/spacer after inhaled steroids, denture hygiene, glycaemic control, review antibiotics
  • If HIV-associated, link to HIV care and ART (the definitive long-term control)
  • Refractory/non-albicans: adjust to echinocandin or voriconazole and confirm diagnosis endoscopically

Drugs & doses

Oral thrush topical: nystatin suspension 100,000 units/mL, 1-5 mL QDS (hold in mouth) 7-14 days OR miconazole oral gel 2.5 mL QDS after food (caution: warfarin interaction)
Oral thrush (extensive/immunocompromised) or first-line in HIV: fluconazole 50-100 mg PO OD 7-14 days
Oesophageal candidiasis: fluconazole 200-400 mg PO/IV on day 1 then 100-200 mg (up to 400 mg) OD for 14-21 days
Fluconazole-refractory: itraconazole solution 200 mg OD, OR voriconazole 200 mg BD, OR an echinocandin (caspofungin 50 mg IV OD / micafungin 150 mg IV OD) [verify local]
Amphotericin B (lipid) for severe azole-refractory disease
Paediatric oral: nystatin suspension; fluconazole 3-6 mg/kg/day for more extensive disease

Disposition

Oral thrush: discharge with topical/oral therapy and cause management. Oesophageal: usually outpatient fluconazole with follow-up; admit if unable to swallow/dehydrated, severely immunocompromised, or refractory needing endoscopy and IV antifungals.

Complications & pitfalls

  • Poor oral intake, dehydration, weight loss
  • Oesophageal stricture/ulceration
  • Dissemination/candidaemia in immunocompromised/neutropenic
  • Recurrence if predisposing factor persists
  • Azole resistance with repeated courses

Exam pearls

  • Oesophageal candidiasis is AIDS-defining - always offer an HIV test, especially if no obvious local cause
  • Inhaled-steroid thrush: advise mouth-rinsing and spacer use - often prevents recurrence
  • Topical agents do not treat oesophageal disease - use systemic fluconazole
  • Miconazole oral gel markedly potentiates warfarin - check INR / choose nystatin
  • Refractory disease: think non-albicans/azole-resistant Candida (C. glabrata/krusei) and reconsider CMV/HSV - scope and biopsy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.